Skip to content
10-Q

Quarterly Report

GroGenesis, Inc.

0001393905-16-000692

← back to feed
Filed
Jan 14, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2016 · Nov 30, 2015 1.85M sh
Shares Outstanding Q2 2016 · Nov 30, 2015 83.42M sh
Stockholders Equity Q2 2016 · Nov 30, 2015 −$52.54K
Stockholders Equity Q2 2016 · May 31, 2015 −$133.81K
Current Liabilities Q2 2016 · Nov 30, 2015 $388.37K
Current Liabilities Q2 2016 · May 31, 2015 $344.23K
Total Liabilities Q2 2016 · Nov 30, 2015 $388.37K
Total Liabilities Q2 2016 · May 31, 2015 $344.23K
Current Assets Q2 2016 · Nov 30, 2015 $186.26K
Current Assets Q2 2016 · May 31, 2015 $45.86K
Total Assets Q2 2016 · Nov 30, 2015 $335.83K
Total Assets Q2 2016 · May 31, 2015 $210.43K
Operating Cash Flow Q2 2016 · Nov 30, 2014 −$12.04K
Cash And Equivalents Q2 2016 · Nov 30, 2014 $147
Cash And Equivalents Q2 2016 · May 31, 2014 $12.19K
Sga Expense Q2 2016 · Nov 30, 2014 $7.74K
Sga Expense Q2 2016 · Nov 30, 2014 $33.41K
Net Income Q2 2016 · Nov 30, 2014 −$69.44K
Net Income Q2 2016 · Nov 30, 2014 −$151.14K
Gross Profit Q2 2016 · Nov 30, 2014 −$415
Gross Profit Q2 2016 · Nov 30, 2014 $22.05K
Cost Of Revenue restated Q2 2016 · Nov 30, 2014 $415
Cost Of Revenue restated Q2 2016 · Nov 30, 2014 $7.51K
Revenue Q2 2016 · Nov 30, 2014 $29.56K